Work

Proteasome and HDAC Inhibitor Therapy in T-Cell Lymphoma (TCL) and Hodgkin Lymphoma (HL): Nuclear Factor Erythroid 2 like 2 (NRF2)-Dependent Cell Death and Function

Year: 2016

Type: article

Source: Blood

DOI: 10.1182/blood.v128.22.3020.3020

Authors: Frank C. Passero, Ravi Dashnamoorthy, Afshin Beheshti, J. Tyson McDonald, Andrew M Evens

Institutions: Tufts Medical Center, Hampton University, Tufts University

Language: English

Topic: Ubiquitin and proteasome pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2980093565

FWCI:

Cites:

Cited by:

Related to: 10